CELZ: Expands ADAPT Trial
Creative Medical Technology receives FDA clearance to expand its ADAPT clinical trial evaluating CELZ-201 for chronic lower back pain associated with degenerative disc disease
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.